Remember that products and treatments may work to varying degrees of success for different people
56 For life sciences companies, the 2026 predictions suggest companies are entering a more constrained and uncertain pricing environment, with tighter guardrails on list price strategy and higher scrutiny on rebate structures
Absolutely, many people do, especially if progress stalls or convenience changes
But no matter what happens, insurance coverage or not, youre guaranteed access to the medication in some form with the monthly $500 (Ozempic/Wegovy/semaglutide) or $600 (Mounjaro/tirzepatide) subscription fee, either via a compounding pharmacy or through a prescription for the name brand drug from a traditional pharmacy
Novo Nordisk abruptly terminated the deal in June 2025, accusing Hims of illegally mass compounding their drugs under the false guise of personalization and using deceptive marketing